-
PTC Therapeutics Announces Date for Fourth Quarter and Full-Year 2025 Financial Results
NASDAQ: $PTCT PTC Therapeutics, a biotechnology company focused on developing innovative treatments for rare diseases, has officially announced the date for the release of its financial performance data for the fourth quarter and the entirety of the 2025 fiscal year. Investors, analysts, and stakeholders can anticipate the official announcement on Thursday, February 19, 2026. This…
-
Decoding the Future of Rare Disease Treatment: Travere Therapeutics at J.P. Morgan Healthcare Conference 2026
NASDAQ: $TVTX The Annual Gathering of Titans: Why J.P. Morgan Matters Every January, the city of San Francisco transforms into the epicenter of the global life sciences industry. The J.P. Morgan Healthcare Conference (JPM) is more than just a series of presentations; it’s where deals are forged, strategies are unveiled, and the trajectory of pharmaceutical…